Drug Profile
Research programme: bradykinin B1 receptor antagonists - Elan
Alternative Names: Benzamide B1 receptor antagonists - Elan; ELN 441958Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Elan Pharmaceuticals
- Class Analgesics
- Mechanism of Action Bradykinin B1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Pain in USA
- 03 Nov 2006 Preclinical trials in Pain in USA (unspecified route)